Numerous signaling pathways have been implicated in acute myeloid leukemia (AML), including the Wnt/β-catenin [14], RAF/MEK/ERK, and PI3K/AKT [15] pathways. This evidence concerns the gene AKT1 and acute myeloid leukemia.